Abstract

Advances in understanding carcinogenesis have fostered many ideas for improving cancer prognostication and treatment. However, development of these ideas has far outpaced the rate of clinical testing. The advent of tissue microarrays has accelerated analysis and reduced the expense of analysis of

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call